Alixia

Alixia is a biotechnology company focused on addressing cancer drug resistance by targeting the tumor ecosystem. The company operates under the premise that cancer is not merely a problem of single mutations, but rather an ecological issue that involves complex interactions among various cell types within a tumor. This innovative perspective leads Alixia to develop therapeutic approaches that consider the dynamics of the tumor microenvironment, which includes factors such as stroma stiffness, inflammatory signals, and metabolic shifts. By studying these interactions, Alixia aims to identify mo…